Zura Bio Limited (ZURA) reported a net loss of $25.8 million, or $0.20 per basic and diluted share, for the third quarter ended September 30, 2026. The company had $187.7 million in cash and cash equivalents at quarter-end.
Zura said enrollment was completed in its Phase 2 TibuSHIELD study in hidradenitis suppurativa and its Phase 2 TibuSURE study in systemic sclerosis. Topline data are expected in the fourth quarter of 2026 and the first half of 2027, respectively.
- Third-quarter research and development expense was $19.5 million, compared with $11.9 million a year earlier.
- General and administrative expense was $9.3 million, compared with $7.6 million in the prior-year period.
- TibuSHIELD enrolled 247 participants, exceeding its target; TibuSURE enrolled 91 participants, also exceeding its target.
- The NEXUS-PMR Phase 2 study is expected to initiate by year-end 2026.
- Zura expects existing cash and cash equivalents to support planned operations through at least the end of 2028.
$ZURA Hedge Fund Activity
We have seen 65 institutional investors add shares of $ZURA stock to their portfolio, and 39 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MPM BIOIMPACT LLC added 4,472,843 shares (+inf%) to their portfolio in Q2 2026, for an estimated $26,389,773
- JPMORGAN CHASE & CO added 4,354,715 shares (+inf%) to their portfolio in Q2 2026, for an estimated $25,692,818
- BLACKROCK, INC. added 3,157,336 shares (+690.3%) to their portfolio in Q2 2026, for an estimated $18,628,282
- PFIZER INC removed 2,300,072 shares (-81.0%) from their portfolio in Q2 2026, for an estimated $13,570,424
- CORMORANT ASSET MANAGEMENT, LP removed 1,450,000 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $8,555,000
- MILLENNIUM MANAGEMENT LLC removed 1,370,424 shares (-90.9%) from their portfolio in Q2 2026, for an estimated $8,085,501
- SATURN V CAPITAL MANAGEMENT LP added 1,361,159 shares (+184.0%) to their portfolio in Q2 2026, for an estimated $8,030,838
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
